India  

India to produce 300 million doses of Sputnik V vaccine in 2021: Report

Mid-Day Friday, 18 December 2020
India will produce about 300 million doses of the Russian Sputnik V coronavirus vaccine in 2021, the head of the Russian Direct Investment Fund (RDIF) Kirill Dmitriev said in an interview with a TV channel.

"In India, we have agreements with four large manufacturers. ...India will produce about 300 million doses or more of the...
0
shares
ShareTweetSavePostSend
 

You Might Like


Related videos from verified sources

COVID vaccine: UK approves AstraZeneca/Oxford University coronavirus jab for use [Video]

COVID vaccine: UK approves AstraZeneca/Oxford University coronavirus jab for use

The UK has ordered 100 million doses from AstraZeneca, which can vaccinate 50 million people.

Credit: Euronews English     Duration: 02:58Published
America's Vaccine Rollout Way Behind Schedule [Video]

America's Vaccine Rollout Way Behind Schedule

With just a few days left in the year, alarm bells are going off among health officials. Many are worried about the slow effort to administer doses of Covid-19 vaccine by the end of the year. The..

Credit: Wochit     Duration: 00:39Published
'India will get 50% of everything...': World's largest vaccine-maker, SII [Video]

'India will get 50% of everything...': World's largest vaccine-maker, SII

Serum Institute of India’s CEO Adar Poonawalla spoke on the Covid-19 vaccine production and roll-out. SII, world's largest vaccine maker, is producing Oxford-Astrazeneca vaccine. SII has applied for..

Credit: HT Digital Content     Duration: 02:53Published

Related news from verified sources

Sputnik V: India to produce 300 million doses of Russian vaccine

Russian Direct Investment Fund head Kirill Dmitriev said that  India will produce about 300 million doses of the Russian Sputnik V coronavirus vaccine in 2021.
Zee News

Dr Reddy's, RDIF begin clinical trials for Russia's Sputnik V vaccine in India

Dr Reddy's and RDIF had entered into a partnership to conduct clinical trials and rights for distribution of the first 100 million doses in India.
DNA